Search

everythinglearnresearchcommunity

for

Search:↓

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Finasteride and SSRIs together increase impotence and low libido risk in men.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Some common medications can harm male fertility, but many effects can be reversed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Hair loss improved with treatment and successful transplant.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Skin reactions from cancer treatments might predict how well the treatments work.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.